Integrating Single-Cell Methods Advances Cell Atlas Generation

Characterizing every cell type in the human body provides essential insight into how tissues and organs function. This knowledge supports progress in healthcare and medicine by revealing the interactions among organ components. This is a core objective of the Human Cell Atlas, an international consortium with 18 scientific networks spanning 103 countries.

Achieving a complete picture presents challenges due to the variety of cell types within organs, including some present in low numbers. Distinguishing these types requires examining molecular characteristics such as active genes or accessible DNA regions for gene regulation. Researchers apply single-cell techniques like scRNAseq or snATACseq, each capturing distinct aspects but none providing the full view. Combining these methods could enhance resolution and understanding.

The Cellular Systems Genomics Group at the Josep Carreras Leukaemia Research Institute addressed this through a study published in Genome Biology. Led by Elisabetta Mereu, the team created integration strategies and an interpretable machine learning algorithm called scOMM. The algorithm classifies cell types across different single-cell methods and assesses integration performance. This combination forms a reliable framework for building cell atlases in complex tissues.

As a proof of concept, Mario Acera Mateos and Jessica Kanglin Li, working with colleagues from MIT and Harvard University, analyzed kidney samples from 19 donors. Examining 199,744 cells, they identified two rare cell types linked to diseased organs that prior kidney cell atlases had missed.

The team validated their approach using heart tissue and additional kidney datasets. This replication confirmed that integration improvements apply broadly, showing the method's reliability across tissues and protocols.

Such efforts enable better characterization of cell diversity and states in challenging samples. They hold potential for studying bone marrow in leukemia patients or lymph nodes in lymphoma, offering clearer views of cellular heterogeneity in these conditions.